Total planned funding: $172,825,624
Allocations
Countries/Regions
Ukraine | $172,825,624 |
Organizational Types
Unknown | $49,672,742 |
NGO | $37,991,481 |
Private Contractor | $33,640,981 |
Own Agency | $22,197,706 |
Multi-lateral Agency | $12,925,607 |
University | $8,527,000 |
Implementing Agency | $4,272,000 |
Other USG Agency | $3,348,107 |
Host Country Government Agency | $250,000 |
Program Areas
Governance and Systems | $77,610,596 |
Treatment | $28,447,596 |
Prevention | $20,360,043 |
Testing | $17,901,583 |
Management and Operations | $15,774,786 |
Care | $12,731,020 |
Budget Codes
OHSS: Health Systems Strengthening | $45,654,157 |
HVSI: Strategic Information | $19,604,953 |
HVCT: Testing: HIV Testing and Counseling | $17,901,583 |
HTXS: Treatment: Adult Treatment | $16,016,482 |
HVMS: Management and Operations | $15,774,786 |
HTXD: Treatment: ARV Drugs | $12,431,114 |
HLAB: Laboratory Infrastructure | $12,351,486 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $9,980,682 |
HVTB: Care: TB/HIV | $7,797,522 |
HVOP: Sexual Prevention: Other Sexual Prevention | $7,507,895 |
HBHC: Care: Adult Care and Support | $2,498,305 |
HKID: Care: Orphans and Vulnerable Children | $2,435,193 |
HMBL: Biomedical Prevention: Blood Safety | $2,083,319 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $293,357 |
HMIN: Biomedical Prevention: Injection Safety | $250,000 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $244,790 |
Top Partner Programs
Not Available:
$45,902,742
Countries/Regions
Chemonics International:
$17,819,470
Countries/Regions
USG Aggregated Agencies:
$15,664,383
Countries/Regions
Deloitte Consulting Limited:
$10,671,511
Countries/Regions